Jasper Therapeutics (JSPR) Shares Outstanding (Entity) (2019 - 2025)
Jasper Therapeutics (JSPR) Shares Outstanding (Entity) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | 62.54 Mn |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | 399.00 Mn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 113.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 133.73 Mn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | 252.88 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 218.28 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 575.47 Mn |
| 10 | Jasper Therapeutics | 20.09 Mn | 20.09 Mn | - | 28.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.17 Mn |
| Sep 30, 2025 | 16.64 Mn |
| Jun 30, 2025 | 16.22 Mn |
| Mar 31, 2025 | 15.02 Mn |
| Dec 31, 2024 | 15.02 Mn |
| Sep 30, 2024 | 15.00 Mn |
| Jun 30, 2024 | 15.11 Mn |
| Mar 31, 2024 | 15.09 Mn |
| Dec 31, 2023 | 11.16 Mn |
| Sep 30, 2023 | 11.08 Mn |
| Jun 30, 2023 | 11.08 Mn |
| Mar 31, 2023 | 8.82 Mn |
| Dec 31, 2022 | 3.80 Mn |
| Sep 30, 2022 | 3.80 Mn |
| Jun 30, 2022 | 3.80 Mn |
| Mar 31, 2022 | 3.79 Mn |
| Dec 31, 2021 | 1.14 Mn |
| Sep 30, 2021 | 496,623.00 |
| Jun 30, 2021 | 1.00 Mn |
| Mar 31, 2021 | 1.00 Mn |